
Mikazest 250 Injection
Marketer
Giriraj Healthcare
Salt Composition
Amikacin (250mg)
Overview Mikazest 250 Injection
Cefazolin 250mg injection combats a broad spectrum of bacterial infections, encompassing urinary tract, bone, joint, lung (pneumonia), brain, and bloodstream infections, among others. Prophylactic use is also common in hospitalized individuals. Its mechanism involves inhibiting bacterial growth. Administered intravenously (IV drip) or intramuscularly by a healthcare professional only, self-administration is strictly prohibited. Consistent, evenly spaced dosing, as directed, is crucial. Complete the prescribed course, regardless of symptom improvement; premature cessation risks relapse or infection exacerbation. Injection site reactions and elevated blood urea nitrogen (BUN) are frequently reported side effects. Persistent side effects or treatment inefficacy necessitate immediate medical consultation. High doses may exceptionally cause vertigo, nephrotoxicity, and ototoxicity. Strict adherence to physician instructions is paramount, including potential monitoring via kidney function, hearing, and urinalysis. Pregnancy is a contraindication; disclose pregnancy, pregnancy intentions, or breastfeeding to your doctor.
Primary Ingredients of Mikazest 250 Injection
No text was provided. Please provide the text you wish me to rephrase.
Uses of Mikazest 250 Injection
Infections caused by bacteria
Major Benefits of Mikazest 250 Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Mikazest 250 Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use Mikazest 250 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Mikazest 250 Injection works:
Mikazest 250 Injection is a bacterial growth inhibitor, acting as an antibiotic by disrupting the production of proteins crucial for bacterial survival.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of Mikazest 250 Injection and alcohol.
PregnancyCONSULT YOUR DOCTOR
Administering Mikazest 250 Injection during pregnancy is contraindicated due to established risks to the fetus. In exceptional, life-threatening circumstances, a physician might consider its use if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingSAFE IF PRESCRIBED
Administering Mikazest 250 Injection while breastfeeding is considered safe. Research in humans indicates minimal drug transfer to breast milk, posing no apparent risk to the infant.
DrivingUNSAFE
Administration of Mikazest 250 Injection can induce drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if such effects manifest.
KidneyCAUTION
Ceftazidime 250mg injection requires careful administration in individuals with impaired renal function. Dosage modification for Ceftazidime 250mg injection may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Mikazest 250 Injection in individuals with liver impairment appears to present minimal risk. Available evidence indicates dose modification may not be necessary; however, physician consultation is recommended.
What if you forget to take Mikazest 250 Injection :
Omitting a scheduled dose of Mikazest 250 Injection necessitates contacting your physician.
Facts to Know About Mikazest 250 Injection
| Label | Value |
|---|---|
| Chemical Type | Aminoglycoside antibiotics |
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
| Behavioral Class | Aminoglycoside antibiotics |
